The neuroethics of pleasure and addiction in public health strategies moving beyond harm reduction: Funding the creation of non-addictive drugs and taxonomies of pleasure

Neuroethics

Volumn 4, Issue 2, 2011, Pages 103-117

  MacKenzie, Robin ^a  

^a UNIVERSITY OF KENT   (United Kingdom)

Author keywords

Addiction; Designer drugs; Harm reduction; Pleasure; Public health

Indexed keywords

CANNABINOID RECEPTOR; COCAINE; DOPAMINE 3 RECEPTOR; DOPAMINE TRANSPORTER; IBOGAINE; NICOTINIC RECEPTOR; OPIATE RECEPTOR; OXYTOCIN; SEROTONIN RECEPTOR;

ADDICTION; ARTICLE; DECISION MAKING; DRUG DEPENDENCE; ETHICS; FUNDING; HARM REDUCTION; HEALTH CARE POLICY; HEALTH CARE PRACTICE; HUMAN; LEARNING; MOTIVATION; NEUROSCIENCE; NONHUMAN; PLEASURE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; REWARD; SUBSTANCE ABUSE; TAXONOMY;

EID: 79960472622     PISSN: 18745490     EISSN: 18745504     Source Type: Journal    
DOI: 10.1007/s12152-010-9074-4     Document Type: Article

References (119)

1. P Boland 2008 British drugs policy: problematising the distinction between legal and illegal drugs and the definition of the 'drugs problem' Probation Journal 55 171 187
2. Nutt, D. 2009. Estimating drug harms: a risky business? Briefing 10, October 2009. Centre for Crime and Justice Studies. London: Centre for Crime and Justice Studies. http://www.crimeandjustice.org.uk/estimatingdrugharmspr.html. Accessed 3 November 2009.
3. RSA Commission. 2007. Drugs-facing facts: the report of the RSA Commission on illegal drugs, communities and public policy. London: Royal Society for the Encouragement of the Arts, Manufacture and Commerce (RSA).
4. W Hall TF Babor 2000 Editorial: cannabis use and public health: assessing the burden Addiction 95 485 490 (Pubitemid 30220244)
5. DN Stephens T Duka 2008 Cognitive and emotional consequences of binge drinking: role of amygdala and prefrontal cortex Philosophical Transactions of the Royal Society. Series B 363 3169 3179
6. Hall, W. 2009. The adverse health effects of cannabis use: what are they, and what are the implications for policy? International Journal of Drug Policy 20: 458-465.
7. Edwards, G. 2004. Matters of substance: drugs-and why everyone's a user. London: Allen Lane.
8. W Hall L Carter KI Morley 2004 Neuroscience research on the addictions: a prospectus for future ethical and policy analysis Addictive Behaviors 29 1481 1495 (Pubitemid 39166000)
9. S Lankenau, et al. 2008 Towards an explanation of subjective ketamine experiences of young injection drug users Addiction Research & Theory 16 273 287
10. R Mackenzie 2006 Addiction in public health and criminal justice system governance: neuroscience, enhancement and happiness research Genomics, Society and Policy 2 92 109
11. R Mackenzie 2008 Feeling good: the ethopolitics of pleasure, psychoactive substance use and public health and criminal justice system governance: therapeutic jurisprudence and the drug courts in the United States of America Social & Legal Studies 17 513 533
12. M Monaghan 2008 Appreciating cannabis: the paradox of evidence in evidence-based policy making Evidence and Policy 4 209 231
13. Travis, A., and D. Summers. 2009. Alan Johnson orders snap review of drugs advice body. Guardian. http://www.guardian.co.uk/politics/2009/nov/02/ drugspolicy-drugs/print. Accessed 2 November 2009.
14. Frijda, N.H. 2010. On the nature and function of pleasure. In Pleasures of the brain, ed. M.L. Kringelbach and K.C. Berridge, 99-112. New York: Oxford University Press.
15. L Degenhardt W Hall M Lynskey 2003 Exploring the association between cannabis use and depression Addiction 98 1493 1504 (Pubitemid 37373847)
16. M Stenbacka Leifman Anders 2001 Can individual competence factors prevent adult substance and alcohol abuse in low and high income areas? Alcohol 25 107 114 (Pubitemid 34016036)
17. Iverson, L. 2007. Science and medical use of marijuana. Oxford: Oxford University Press.
18. Leknes, S., and I. Tracey. 2010. Pain and pleasure: masters of mankind. In Pleasures of the brain, ed. M.L. Kringelbach and K.C. Berridge, 320-336. New York: Oxford University Press.
19. KC Berridge ML Kringelbach 2008 Affective neuroscience of pleasure: reward in humans and animals Psychopharmacology 199 457 480
20. ML Kringelbach KC Berridge 2009 Towards a functional neuroanatomy of pleasure and happiness Trends in Cognitive Science 13 479 487
21. Schroeder, T. 2004. Three faces of desire. New York: Oxford University Press.
22. Clark, R.E. 2009. Resistance to change: unconscious knowledge and the challenge of unlearning. In Changing institutions, environments and people, ed. D.C. Berliner and H. Kupwermintz, 75-94. New York: Routledge.
23. Kringelbach, M.L., and K.C. Berridge. 2010. Fundamental pleasure questions. In Pleasures of the brain, ed. M.L. Kringelbach and K.C. Berridge, 7-26. New York: Oxford University Press.
24. Cabanac, M. 2010. The dialectics of pleasure. In Pleasures of the brain, ed. M.L. Kringelbach and K.C. Berridge, 113-124. New York: Oxford University Press.
25. KC Berridge TE Robinson J Wayne Aldridge 2009 Dissecting components of reward: 'liking', 'wanting' and learning Current Opinion in Pharmacology 9 65 73
26. SE Hyman RC Malenka EJ Nestler 2006 Neural mechanisms of addiction: the role of reward-related learning and memory Annual Review of Neuroscience 29 565 598 (Pubitemid 44476856)
27. Leyton, M. 2010. The neurobiology of desire: dopamine and the regulation of mood and motivational states in humans. In Pleasures of the brain, ed. M.L. Kringelbach and K.C. Berridge, 222-243. New York: Oxford University Press.
28. DP Figlewicz SC Benoit 2009 Insulin, leptin and food reward: update 2008 American Journal of Physiological Regulation Integrating Comparative Physiology 296 R9 R19
29. MC Potenza 2008 The neurobiology of pathological gambling and drug addiction: an overview and new findings Philosophical Transactions of the Royal Society. Series B 363 3181 3189
30. ND Volkow, et al. 2008 Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology Philosophical Transactions of the Royal Society. Series B 363 3191 3200
31. F Koob George ND Volkow 2009 Neurocircuitry of addiction Neuropharmacology Reviews np/npp. 2009.110
32. GF Koob M Le Moal 2008 Addiction and the brain anti-reward system Annual Review of Psychology 59 29 53
33. BJ Everitt, et al. 2008 Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction Philosophical Transactions of the Royal Society. Series B 363 3125 3135
34. KC Berridge 2009 'Liking' and 'wanting' food rewards: brain substrates and roles in eating disorders Physiology & Behavior 97 537 550
35. KC Berridge 2007 The debate over dopamine's role in reward: the case for incentive salience Psychopharacology 191 391 431 (Pubitemid 46355895)
36. KC Berridge TE Robinson 2003 Parsing reward Trends in Neurosciences 26 507 513 (Pubitemid 37025790)
37. MR Kowe ML Butryn 2007 Hedonic humger: a new dimension of appetite? Physiology & Behavior 91 432 439 (Pubitemid 47016537)
38. Kringelbach, M.L. 2010. The hedonic brain: a functional neuroanatomy of human pleasure. In Pleasures of the brain, ed. M.L. Kringelbach and K.C. Berridge, 202-221. New York: Oxford University Press.
39. ML Kringelbach 2005 The orbitofrontal cortex: linking reward to hedonic experience Nature Reviews Neuroscience 6 691 702 (Pubitemid 43160318)
40. TE Robinson KC Berridge 2008 The incentive sensitisation theory of addiction: some current issues Philosophical Transactions of the Royal Society. Series B 363 3137 3146
41. SR Quartz 2009 Reason, emotion and decision-making: risk and reward computation with feeling Trends in Cognitive Science 13 209 216
42. Shubin, N. 2008. Your inner fish: a journey into the 3.5-billion-year history of the human body. London: Allen Lane.
43. GC Chiara V Bassareo 2006 Reward system and addiction: what dopamine does and doesn't do Current Opinion in Pharmacology 7 69 75
44. MR Lowe ML Butryn 2007 Hedonic hunger: a new dimension of appetite Physiology & Behavior 91 432 439 (Pubitemid 47016537)
45. NM Avena P Rada BC Hoebel 2009 Sugar and fat bingeing have notable differences in addictive-like behaviour Journal of Nutrition 139 623 628
46. JH Halpern, et al. 2005 Psychological and cognitive effects of long term peyote use among Native Americans Biological Psychiatry 58 624 631 (Pubitemid 41565577)
47. Singer, T., H.D. Critchley, and K. Preuschoff. 2009. A common role for the insula in feelings, empathy and uncertainty. Trends in Cognitive Sciences 13: 334-340.
48. AD Craig 2009 How do you feel-now? The anterior insula and human consciousness Nature Reviews Neuroscience 10 59 70
49. AD Craig 2004 Human feelings: why are some more aware than others? Trends in Cognitive Sciences 8 239 241 (Pubitemid 38692510)
50. AD Craig 2003 Interoception: the sense of the physiological condition of the body Current Opinion in Neurobiology 13 500 505 (Pubitemid 37088242)
51. AD Craig 2002 How do you feel? Interoception: the sense of the physiological condition of the body Nature Reviews Neuroscience 3 655 666 (Pubitemid 135706673)
52. T Franklin, et al. 2002 Decreased grey matter concentration in the insular, orbitofrontal, cingulated and temporal cortices of cocaine patients Biological Psychiatry 51 134 142 (Pubitemid 34127903)
53. DL Lubman M Yucel C Pantelis 2004 Addiction, a condition of compulsive behaviour? Neuroimaging and neuropsychological evidence of inhibitory dysregulation Addiction 99 1491 1502 (Pubitemid 39664821)
54. JA Zombeck, et al. 2008 Neuroanatomical specificity of conditioned responses to cocaine versus food in mice Physiology & Behavior 93 637 650 (Pubitemid 351208447)
55. RD Mayfield RA Harris MA Schuckit 2008 Genetic factors influencing alcohol dependence British Journal of Pharmacology 154 275 287 (Pubitemid 351670604)
56. MA Nader, et al. 2008 Positron emission tomography imaging studies of dopamine receptors in primate models of addiction Philosophical Transactions of the Royal Society. Series B 363 3223 3232
57. CP O'Brien 2008 Evidence-based treatments of addiction Philosophical Transactions of the Royal Society. Series B 363 3277 3286
58. TJR Beveridge, et al. 2008 Parallel studies of cocaine-related neural and cognitive impairment in humans and monkeys Philosphical Transactions of the Royal Society. Series B 363 3257 3266
59. U Heberlein, et al. 2008 Drosophila, a genetic model system to study cocaine-related behaviours: a review with focus on LIM-only proteins Neuropharmacology 10.1016/jneuropharm.2009.07.023
60. LM Squeglia J Jacobus SF Tapert 2009 The influence of substance use on adolescent brain development Clinical EEG & Neuroscience 40 31 38
61. SC McQuown, et al. 2009 Age-dependent effects of low-dose nicotine treatment on cocaine-induced behavioural plasticity in rats Psychopharmacology 207 143 152
62. L Kirisci, et al. 2006 Individual differences in childhood neurobehaviour disinhibition predict decision to desist substance use during adolescence and substance use disorder in young adulthood: a prospective study Addictive Behaviors 31 686 695
63. ET Moolchan R Mermelstein 2002 Research on tobacco use among teenagers: ethical challenges Journal of Adolescent Health 30 409 417 (Pubitemid 34606938)
64. D Gulick TJ Gould 2008 Interactive effects of ethanol and nicotine on learning in C57BL/6 J mice depend on both dose and duration of treatment Psychopharmacology 196 483 495 (Pubitemid 351191179)
65. JC Crabbe 2008 Neurogenetic studies of alcohol addiction Philosophical Transactions of the Royal Society. Series B 363 3201 3211
66. J Le Merrer, et al. 2009 Reward processing by the opioid system in the brain Physiological Review 89 1379 1412
67. ID Montoya F Vocci 2008 Novel medications to treat addictive disorders Current Psychiatry Reports 10 392 398
68. S Rahman 2008 Editorial: hot topic, drug addiction and brain targets, from preclinical research to pharmacotherapy CNS & Neurological Disorders-Drug Targets 7 391 392
69. W Hall 2005 Will nicotine genetics and a nicotine vaccine prevent cigarette smoking and smoking-related diseases? PLoS Medicine 2 860 863
70. CCY Wong G Schumann 2008 Genetics of addictions: strategies for addressing heterogeneity and polygenicity of substance use disorders Philosophical transactions of the Royal Society. Series B 363 3213 3222
71. Lawrence, A.J., P.M. Beart, and P.W. Kalivas. 2008. Neuropharmacology of addiction: setting the scene. British Journal of Pharmacology 154: 259-260.
72. PW Kalivas 2007 Neurobiology of cocaine addiction: implications for new pharmacotherapy American Journal of Addiction 16 71 78 (Pubitemid 46633928)
73. PW Kalivas 2009 Glutamate transmission in addiction Neuropharmacology 56 169 173
74. HC Fox ED Jackson R Sinha 2009 Elevated cortisol and learning and memory deficits in cocaine dependent individuals: relationship to relapse outcomes Psychoneuroendocrininology 34 1198 1207
75. MH Imordino-Yang A Damasio 2007 We feel, therefore we learn: the relevance of affective and social neuroscience to education Journal of Compilation 1 3 10
76. BC Wittmann, et al. 2008 Mesolimbic interaction of emotional valence and reward improves memory formation Neuropsychologia 46 1000 1008
77. Grant, J.E., and S.W. Kim. 2006. Medication management of pathological gambling. Minnesota Medicine http://www.minnesoatamedicine.com/PastIssues/ September2006/ClinicalGrantSeptember Accessed 3 November 2009.
78. Berkus, E. 2007. The link between psychotic disorders and substance use. Psychiatric Times 24 http://www.psychiatrictimes.com/print/article/10168/46501? printable=true. Accessed 3 November 2009.
79. S Ross E Peselow 2009 The neurobiology of addictive disorders Clinical Neuropharmacology 32 269 276
80. M-F O'Connor, et al. 2008 Craving love? Enduring grief activates brain's reward center Neuroimage 42 969 972
81. M Solinas SK Goldberg D Piomelli 2008 The endocannibinoid system in brain reward processes British Journal of Pharmacology 154 369 383 (Pubitemid 351670594)
82. B Le Foll DA Gorelick SR Goldberg 2009 The future of endocannabinoid oriented clinical research after CB1 antagonists Psychopharmacology 205 1506 1507
83. WA Corrigall 2009 Hypocretin mechanisms in nicotine addiction: evidence and speculation Psychopharmacology 206 23 37
84. MJ Gullo S Dawe 2008 Impulsivity and adolescent substance use: rashly dismissed as all bad? Neuroscience and Biobehavioral Reviews 32 1507 1518
85. NH Naqvi A Bechara 2008 The hidden island of addiction: the insula Trends in Neuroscience 32 56 67
86. K Domschke, et al. 2009 Interioceptive sensitivity to anxiety and anxiety disorders: an overview and integration of neurobiological findings Clinical Psychology Review 10.1016/.cpr.2009.08.008
87. Koob, G.F. 2009. Dynamics of neuronal circuits in addiction: reward, anti-reward and emotional memory. Pharmacopsychiatry 42: 532-541.
88. K Evers 2007 Perspectives on memory manipulation: using beta-blockers to cure post-traumatic stress disorder Cambridge Quarterly of Healthcare Ethics 16 138 146
89. B Boutrel 2008 A neuropeptide-centric view of psychostimulant addiction British Journal of Pharmacology 154 343 357 (Pubitemid 351670597)
90. PJ Fudala RE Johnson 2006 Development of opioid formulations with limited diversion and abuse potential Drug and Alcohol Dependence 83 S40 S47
91. JM Mitchell, et al. 2009 Natrexone aversion and treatment efficacy are greatest in humans and rats that actively consume high levels of alcohol Neurobiology of Disease 33 72 80
92. U Maas S Strubelt 2006 Fatalities after taking ibogaine in addiction treatment could be related to sudden cardiac death caused by autonomic dysfunction Medical Hypotheses 67 960 964 (Pubitemid 44062110)
93. K Alper H Lotsof 1999 Treatment of acute opiod withdrawal with ibogaine American Journal of Addiction 8 234 242 (Pubitemid 29409791)
94. Mackenzie, R. 2009. Reframing the good death: enhancing choice in dying, neuroscience, end of life research and the potential of psychedelics in palliative care. In Law, Mind and Brain, ed. M. Freeman and O. Goodenough, 239-263. London: Ashgate.
95. H Garavan JN Kaufman R Hester 2008 Acute effects of cocaine on the neurobiology of cognitive control Philosophical Transactions of the Royal Society. Series B 363 3267 3276
96. IS McGregor PD Callaghan GE Hunt 2008 From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long term adverse consequences of drug use? British Journal of Pharmacology 154 358 368 (Pubitemid 351670596)
97. Johnson, M.W., W.A. Richards, and R.R. Griffiths. 2008. Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology 22: 603-620.
98. RG Santos, et al. 2007 Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members Journal of Ethnopharmacology 112 507 513 (Pubitemid 47023036)
99. W Hall MacDonald Christie D Currow 2005 Cannabinoids and cancer: causation, remediation and palliation Lancet Oncology 6 35 42 (Pubitemid 40100410)
100. K Burns A Bechara 2007 Decision making and free will: a neuroscience perspective Behavioral Sciences and the Law 25 263 280 (Pubitemid 46733425)
101. G Northoff 2006 Neuroscience of decision making and informed consent: an investigation in neuroethics Journal of Medical Ethics 32 70 73 (Pubitemid 43230575)
102. V Vengeliene, et al. 2008 Neuropharmacology of alcohol addiction British Journal of Pharmacology 154 299 315 (Pubitemid 351670598)
103. A Bechara H Damasio 2002 Decision-making and addiction (part I): impaired activation of somatic states in substance dependent individuals when pondering decisions with negative future consequences Neuropsychologia 40 1675 1689 (Pubitemid 34462876)
104. A Bechara S Dolan A Hines 2002 Decision-making and addiction (part II): myopia for the future or hypersensitivity to reward? Neuropsychologia 40 1696 1705
105. Mackenzie, R., and M. Sakel. 2010. The neuroscience of cruelty as brain damage: legal framings of capacity and ethical issues in the neurorehabilitation of motor neurone disease and behavioural variant fronto-temporal dementia patients. In Law and neuroscience: current legal issues, ed. M. Freeman. Oxford: Oxford University Press.
106. R Mackenzie J Watts 2009 Callous/unemotional conduct disorder as a learning disability Tizard Learning Disability Review 14 38 44
107. A Verdejo-Garcia A Bechara 2008 A somatic marker theory of addiction Neuropharmacology 56 48 62
108. DV Jeste E Saks 2006 Decisional capacity in mental illness and substance use disorders: empirical database and policy implications Behavioral Sciences and the Law 24 607 628 (Pubitemid 44328722)
109. MA Gray HD Critchley 2007 Interoceptive basis to craving Neuron 54 183 186 (Pubitemid 46561204)
110. MP Paulus SF Tapert G Schulteis 2009 The role of interoception and alliesthesia in addiction Pharmacology, Biochemistry and Behavior 94 1 7
111. R Goldstein, et al. 2009 The neurocircuitry of impaired insight in drug addiction Trends in Cognitive Science 13 372 380
112. MT Gray 2005 The shifting sands of self: a framework for the experience of self in addiction Nursing Philosophy 6 119 130
113. P Shinebourne JA Smith 2009 Alcohol and the self: an interpretative phenomenological analysis of the experience of addiction and its impact on the sense of self and society Addiction Research & Theory 17 152 167
114. RD Baler ND Volkow 2006 Drug addiction: the neurobiology of disrupted self-control Trends in Molecular Medicine 12 559 566 (Pubitemid 44780200)
115. C Folini E Racine 2009 Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement BMC Medical Ethics 10 9 19
116. H Forstl 2009 Neuro-enhancement: brain doping Nervenarzt 7 840 846
117. LC Lenzken, et al. 2008 Cognition enhancers: between treating the body and doping the mind Pharmacological Research 57 196 213
118. M Soyka 2009 Neuro-enhancement from an addiction specialist's viewpoint Nervenarzt 80 837 839
119. PR Wolpe 2002 Treatment, enhancement and the ethics of neurotherapeutics Brain & Cognition 50 387 395